Dadachanji Group Launches KAISHA Pharma with $45 Million Investment
Dadachanji Group has launched KAISHA Pharma, a global pharmaceutical packaging company, with an initial investment of $45 million. Building on 35 years of experience, KAISHA Pharma will offer a range of tubular glass packaging products and Ready-to-Use platforms for pharmaceutical and biotechnology firms in India and worldwide. The company aims to enhance fill-finish operations and develop specialty containment solutions for advanced therapeutics. Its manufacturing facility will cover over 300,000 square feet with advanced production and testing equipment, alongside a European business development office.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 34/100.
Outlets measured: news18, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 4 Sept, 04:10 am. Other outlets followed.
- 1